Stevanato Group.
Italian multinational company
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
TD Cowen upgraded shares of Stevanato Group on August 10, 2026.Some support3 reports
-
Stevanato Group is expanding its operations and providing biopharma solutions across Africa, Europe, the Middle East, and Latina.Well supported3 reports
-
Stevanato Group and Catalyst Pharmaceutical were analyzed as value stocks for investors on July 9, 2025.Speculative1 report
-
Stevanato Group secured financing on July 23, 2025, to fund CAPEX investments and scaling in North America.Some support1 report
-
BeOne Medicines (Switzerland) and Stevanato Group are companies that operate in the medical and pharmaceutical sectors.Some support1 report
-
Stevanato Group, based in Italy, participated in global healthcare conferences in New York City.Some support3 reports
No events began in the chosen period. Widen it, or reset.
Around Stevanato Group this week
News at the entities that move Stevanato Group most-
SEC StructuralA company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.Moves Stevanato Group
-
North America StructuralAlberta government engaged with U.S. state legislators in Sacramento to promote its perspective across North America.Moves Stevanato Group
-
Europe StructuralLee Jae Myung's administration is considering major adoption policy changes following a commission finding government responsibility for fraud.Moves Stevanato Group
-
BioNano Genomics OperationalBioNano Genomics traded on the Nasdaq stock exchange on July 9, 2026.Moves Stevanato Group
-
TD Cowen Mentioned togetherLeerink Partners began coverage on Shattuck Labs shares, and TD Cowen subsequently raised the shares to a strong-buy rating.Moves Stevanato Group
-
South America Shared contextUS beef exports are being received by markets in South America and the Middle East.Moves Stevanato Group
Connections
The 15 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Lisa Miles Structural
Lisa Miles serves as the Investor Relations contact for Stevanato Group.
-
SEC Structural
Stevanato Group is subject to regulatory oversight by the SEC, evidenced by insider trading disclosures.
-
North America Structural
Stevanato Group relies on the North American market for its bio-pharma and healthcare integrated solutions.
-
BioNano Genomics Operational
Two healthcare companies are currently competing for investment opportunities.
-
Europe Structural
Stevanato Group provides biopharma solutions that operate within the market and regulatory framework of Europe.
-
Rapid Micro Biosystems Operational
Both healthcare companies are observed competing for investment capital in the market.
-
Latina Operational
Stevanato Group is expanding operations to support HVS demand in Latina.
-
Grifols Operational
Grifols is actively compared to Stevanato Group based on superior earnings outlook and valuation metrics.
Show all 15 connections
-
Middle East Shared context
Stevanato Group provides biopharma and healthcare solutions operating within the Middle East region.
-
South America Shared context
The company operates within the context of South America, which serves as its operational base and market.
-
TD Cowen Mentioned together
TD Cowen provided a share upgrade recommendation for Stevanato Group.
-
New York City Shared context
Stevanato Group participates in conferences and events held in New York City.
-
Africa Shared context
Stevanato Group operates within the African biopharma and healthcare market.
-
Fishers Shared context
Stevanato Group is expanding its operations to support demand within the Fishers area.
-
Italy Shared context
Stevanato Group is located and operates within Italy.
History
Events by the month they beganOctober 2026
2 eventsAugust 2026
1 eventJune 2026
5 events- Stevanato Group is expanding its operations and providing biopharma solutions across Africa, Europe, the Middle East, and Latina.
- Stevanato Group and Catalyst Pharmaceutical were analyzed as value stocks for investors on July 9, 2025.
- Stevanato Group secured financing on July 23, 2025, to fund CAPEX investments and scaling in North America.
- BeOne Medicines (Switzerland) and Stevanato Group are companies that operate in the medical and pharmaceutical sectors.
- Stevanato Group, based in Italy, participated in global healthcare conferences in New York City.